- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06181747
Development of Attention and Its Relationship With Emotions in Children and Adolescents
February 29, 2024 updated by: Institute of Psychology, Chinese Academy of Sciences
Research on the Development of Attention and Its Relationship With Emotions in Children and Adolescents
Our aim was to describe the development and usability of a mobile device-based game therapy software for ADHD.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
A total of 51 ADHD children and 52 healthy children were included in the study.
At baseline, subjects underwent tests such as ADHD symptom-related scale assessments, computer-assisted information processing tests, and physiological-psychological tests, after which participants completed a 4-week game intervention training at home.
After complete completion of the intervention, subjects repeated all tests from the baseline period and answered treatment satisfaction questions.
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China
- Institute of Psychology, Chinese Academy of Sciences
-
-
Jiangsu
-
Nanjing, Jiangsu, China
- Nanjing Normal University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- ADHD-a. Age between 6-12 years, any gender.
- ADHD-b. Outpatient patients diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
- ADHD-c. Patients and/or their guardians willing to participate in the study and provide informed consent. Participants aged 8 and above should also sign a child's informed consent form.
- HC. The control group of healthy participants are recruited from a secondary school in Nanjing, matching the age and gender of the ADHD group.
Exclusion Criteria:
- a. Neurodevelopmental disorders such as cerebral palsy, epilepsy, adrenoleukodystrophy, and other similar conditions.
- b. Severe mental disorders including tic disorders, autism spectrum disorders, intellectual disability, schizophrenia, bipolar disorder, depressive disorders, specific learning disorders, and other significant psychiatric conditions.
- c. Individuals exhibiting ADHD-like symptoms due to hearing impairments.
- d. Requirement of any central nervous system medication (including both traditional and Western medicine as well as dietary supplements) such as antipsychotics or antidepressants at any stage of the study.
- e. Patients who have received systematic treatment with two different categories of ADHD medications without improvement.
- f. Individuals with color blindness or any other condition that would prevent proper use of the software.
- g. History of or current gaming addiction.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ADHD group
Participants are required to engage in game training at home for 5 days per week, with each session lasting 20-25 minutes.
The game is equipped with anti-addiction measures, limiting the maximum daily game time to 30 minutes.
Participants will adjust their game training based on their own abilities, and as the training progresses, the game will adaptively adjust the difficulty level and change levels accordingly.
|
The cognitive impairment corresponding to the symptoms, which we are interested in, focuses on executive inhibition, motor inhibition, sustained attention, selective attention, working memory, and planning ability.
The training content will be presented in different scenarios as effective training components.
The story line of the warrior breakthrough runs through the whole game, each level is adapted according to the functional damage areas of different patients, and each level involves reward and punishment mechanisms to keep the interest of the players, the difficulty gradient of each level is kept moderate, and the game includes design elements such as space, time, object attributes, actions, rules, skills, and probabilities, etc., which ultimately completes Save the Muse Home, a serious game for the treatment of ADHD.
|
|
Experimental: healthy control group
Participants are required to engage in game training at home for 5 days per week, with each session lasting 20-25 minutes.
The game is equipped with anti-addiction measures, limiting the maximum daily game time to 30 minutes.
Participants will adjust their game training based on their own abilities, and as the training progresses, the game will adaptively adjust the difficulty level and change levels accordingly.
|
The cognitive impairment corresponding to the symptoms, which we are interested in, focuses on executive inhibition, motor inhibition, sustained attention, selective attention, working memory, and planning ability.
The training content will be presented in different scenarios as effective training components.
The story line of the warrior breakthrough runs through the whole game, each level is adapted according to the functional damage areas of different patients, and each level involves reward and punishment mechanisms to keep the interest of the players, the difficulty gradient of each level is kept moderate, and the game includes design elements such as space, time, object attributes, actions, rules, skills, and probabilities, etc., which ultimately completes Save the Muse Home, a serious game for the treatment of ADHD.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Continuous Performance Test, CPT
Time Frame: baseline and post (an average of 30days after baseline)
|
CPT software is one of the commonly used tools for examining attention and is a computer-assisted information processing test with objective results, independent of supervisors, and is the most widely used experimental paradigm in current research.
The CPT paradigm adopted in this study is the presence of a white boxed area on a black background on the calculator screen, with white squares randomly appearing above or below the white boxed area, requiring the target stimulus to be a right mouse button press when the square appears below it.
|
baseline and post (an average of 30days after baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Swanson Nolan, and Pelham-IV rating scales, SNAP-IV
Time Frame: baseline and post (an average of 30days after baseline)
|
The SNAP-IV rating scales (Swanson Nolan, and Pelham-IV rating scales, SNAP-IV) is a revised version of the Swanson, Nolan Pelham (SNAP) (Swanson, et al., 1983), which was developed based on the description of ADHD symptoms in the Diagnostic and Statistical Manual of Mental Disorders (DSM).
It consists of three subscales: attention deficit, hyperactivity-impulsivity, and oppositional defiance, and is mainly used for screening, diagnostic support, and assessment of treatment efficacy and symptom improvement in children and adolescents between the ages of 6 and 18 years.
Although SNAP-IV consists of 3 subscales, it is one scale, just like SDQ and BRIEF mentioned later.
|
baseline and post (an average of 30days after baseline)
|
|
Strengths and Difficulties Questionnaire, SDQ
Time Frame: baseline and post (an average of 30days after baseline)
|
The SDQ is a brief behavioral screening questionnaire designed and developed by American psychologist Goodman R in 1997 based on the Diagnostic and Statistical Manual of Mental Disorders-IV and the Diagnostic Criteria for the Classification of Mental and Behavioral Disorders, 10th Edition (ICD-10).
It is used to assess behavioral and emotional problems in children and adolescents and has good reliability and validity.
|
baseline and post (an average of 30days after baseline)
|
|
Behavior Rating Inventory of Executive Function, BRIEF
Time Frame: baseline and post (an average of 30days after baseline)
|
The scale consists of 86 entries in two major areas: the Behavior Management Index (BMI), which includes the three subscales of Inhibition, Conversion, and Affect, and Control, Conversion and Affect, and Control subscales; and the Metacognitive Functioning Index: five subscales including Task Initiation, Working Memory, Planning, Organization, and Monitoring.
It has good reliability and validity.
|
baseline and post (an average of 30days after baseline)
|
|
Anti-saccade task
Time Frame: baseline and post (an average of 30days after baseline)
|
First, present the central gaze point cross for 2s, the central cross disappeared while the target appeared as a green dot, randomly present four positions at 3°, 6° left and right sides horizontally, presentation time 1000ms, each angle randomly appeared 5 times for a total of 20 times, when the response is over a 300ms feedback point will appear in the correct position.
|
baseline and post (an average of 30days after baseline)
|
|
Delay-saccade task
Time Frame: baseline and post (an average of 30days after baseline)
|
Presentation of the central gaze point cross for 2 s, the target stimulus appeared (the cross continued to exist) for the green origin randomly presented at four positions 3°, 6° left and right sides horizontally, presentation time 100 ms.
Subsequently, the gaze point was presented only at the center of the screen for 1, 3, and 5 s, staring at the cross intently, and then the screen appeared to go blank for 1.4 s, the subject recalled looking at the beginning of the target, and the latter a 200-ms feedback point appeared at the correct location.
|
baseline and post (an average of 30days after baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Zhengkui Liu, Ph.D., Institute of Psychology, Chinese Academy of Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2023
Primary Completion (Actual)
May 5, 2023
Study Completion (Actual)
May 10, 2023
Study Registration Dates
First Submitted
December 1, 2023
First Submitted That Met QC Criteria
December 12, 2023
First Posted (Actual)
December 26, 2023
Study Record Updates
Last Update Posted (Actual)
March 1, 2024
Last Update Submitted That Met QC Criteria
February 29, 2024
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E2KM011639-K12023000015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Disorder With Hyperactivity
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Istituto Giannina GasliniUniversity of Genova; IRCCS Fondazione Stella MarisRecruitingADHD - Attention Deficit Disorder With HyperactivityItaly
-
Dlniya Ismail RashidActive, not recruitingADHD - Attention Deficit Disorder With HyperactivityIraq
-
Hoskinson Health and Wellness ClinicWithdrawnAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Tanta UniversityActive, not recruitingAttention Deficit Disorder With Hyperactivity (ADHD)Egypt
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Gaziantep Islam Science and Technology UniversityCompletedAttention Deficit Disorder With Hyperactivity (ADHD)Turkey (Türkiye)
-
Medipol UniversityEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD)Turkey (Türkiye)